Back

PVI, PeerView Institute for Medical Education

  • Carcinoma, Neuroendocrine
  • Prognosis

From Poor Prognosis to Emerging Clinical Potential A Visual Journey of Targeted Therapy Innovation in Extrapulmonary Neuroendocrine Carcinomas

From Poor Prognosis to Emerging Clinical Potential A Visual Journey of Targeted Therapy Innovation in Extrapulmonary Neuroendocrine Carcinomas

Credit & MOC Details

Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.

Credit types

AMA PRA Category 1 Credit™Up to 0.5 credits

MOC types

No MOC

FDA REMS

No

Qualifies for MIPS

No

Pricing

Free

Reported to ACCME by the provider

  • On-demand / recorded video
  • Credit · Up to 0.5 credits
  • Commercial Support
  • Released
    Jan 8, 2026
  • Last day to claim credit
    Jan 8, 2027 3 months left